Literature DB >> 27702628

Effects of repeated high-dose methamphetamine and ceftriaxone post-treatments on tissue content of dopamine and serotonin as well as glutamate and glutamine.

Yusuf S Althobaiti1, Atiah H Almalki2, Sujan C Das2, Fahad S Alshehri1, Youssef Sari3.   

Abstract

Repeated exposure to high doses of methamphetamine (METH) is known to alter several neurotransmitters in certain brain regions. Little is known about the effects of ceftriaxone (CEF), a β-lactam antibiotic, known to upregulate glutamate transporter subtype 1, post-treatment on METH-induced depletion of dopamine and serotonin (5-HT) tissue content in brain reward regions. Moreover, the effects of METH and CEF post-treatment on glutamate and glutamine tissue content are not well understood. In this study, Wistar rats were used to investigate the effects of METH and CEF post-treatment on tissue content of dopamine/5-HT and glutamate/glutamine in the nucleus accumbens (NAc) and prefrontal cortex (PFC). Rats received either saline or METH (10mg/kg, i.p. every 2h×4) followed by either saline or CEF (200mg/kg, i.p, every day×3) post-treatment. METH induced a significant depletion of dopamine and 5-HT in the NAc and PFC. Importantly, dopamine tissue content was completely restored in the NAc following CEF post-treatment. Additionally, METH caused a significant decrease in glutamate and glutamine tissue content in PFC, and this effect was attenuated by CEF post-treatment. These findings demonstrate for the first time the attenuating effects of CEF post-treatment on METH induced alterations in the tissue contents of dopamine, glutamate, and glutamine.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Ceftriaxone; Dopamine; Glutamate; Glutamine; Methamphetamine; Serotonin

Mesh:

Substances:

Year:  2016        PMID: 27702628     DOI: 10.1016/j.neulet.2016.09.058

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Effects of sequential ethanol exposure and repeated high-dose methamphetamine on striatal and hippocampal dopamine, serotonin and glutamate tissue content in Wistar rats.

Authors:  Atiah H Almalki; Sujan C Das; Fahad S Alshehri; Yusuf S Althobaiti; Youssef Sari
Journal:  Neurosci Lett       Date:  2017-11-22       Impact factor: 3.046

2.  Verification of a genetic locus for methamphetamine intake and the impact of morphine.

Authors:  Emily C Eastwood; Amy J Eshleman; Aaron Janowsky; Tamara J Phillips
Journal:  Mamm Genome       Date:  2017-11-10       Impact factor: 2.957

3.  The GLT-1 enhancer clavulanic acid suppresses cocaine place preference behavior and reduces GCPII activity and protein levels in the rat nucleus accumbens.

Authors:  Helene L Philogene-Khalid; Mary F Morrison; Nune Darbinian; Michael E Selzer; Joseph Schroeder; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2022-01-12       Impact factor: 4.492

4.  Metabolite Alternations in the Dopamine Circuit Associated with Methamphetamine-Related Psychotic Symptoms: A Proton Magnetic Resonance Spectroscopy Study.

Authors:  Javad Sheikhi Koohsar; Fariborz Faeghi; Raheleh Rafaiee; Mohammad Niroumand Sarvandani; Sadegh Masjoodi; Hamid Kalalian Moghaddam
Journal:  Iran J Psychiatry       Date:  2022-01

5.  The distinct roles of various neurotransmitters in modulating methamphetamine-induced conditioned place preference in relevant brain regions in mice.

Authors:  Hongliang Su; Junmei Bai; Yao Fan; Tingting Sun; Yan Du; Yanhua Li; Zhiwen Wei; Teng Chen; Xiangjie Guo; Keming Yun
Journal:  Neuroreport       Date:  2022-02-02       Impact factor: 1.837

6.  The potential antiepileptic activity of astaxanthin in epileptic rats treated with valproic acid.

Authors:  Yussra Ata Yaseen Abdulqader; Hala Salah Abdel Kawy; Huda Mohammed Alkreathy; Nisreen Abdullah Rajeh
Journal:  Saudi Pharm J       Date:  2021-04-09       Impact factor: 4.330

7.  Differential effects of synthetic psychoactive cathinones and amphetamine stimulants on the gut microbiome in mice.

Authors:  Mariana Angoa-Pérez; Branislava Zagorac; Andrew D Winters; Jonathan M Greenberg; Madison Ahmad; Kevin R Theis; Donald M Kuhn
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.